New appointment at Silicos
This article was originally published in Scrip
Executive Summary
Silicos (Belgium), a privately held computational drug design biotechnology company, has appointed Dr Jack Elands chief business officer. Dr Elands, a neuropharmacologist by training, began his career as a research scientist at Marion Merrell Dow (now Sanofi-Aventis) and has since served in several business development roles, most recently at Sidec.